medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

COVID-19 pandemic in the African continent:
Forecasts of cumulative cases, new infections, and mortality

Achoki, T 1,2,3; Alam, U3; Were, L4; Gebremedhin, T5; Senkubuge, F1; Lesego, A6; Liu, S7;
Wamai, R8; Kinfu, Y ¬ß 9,10,11,12
School of Health Systems and Public Health, University of Pretoria, South Africa

1

Mass Sciences, Boston, MA.

2

Africa Institute for Health Policy Foundation, Kenya.

3

Department of Health Sciences & Department of Global Health, Boston University, Boston, MA.

4

5

Faculty of Business, Government and Law, University of Canberra, Australia
6

7

8

Kudu Communications - Health Services, Gaborone, Botswana

Faculty of Science and Technology, University of Canberra, Australia

Department of Cultures, Societies and Global Studies, and Integrated Initiative for Global Health,
Northeastern University, Boston, MA
9

Faculty of Health, University of Canberra, Australia
10

11

12

College of Medicine, Qatar University, Qatar

Department of Health Metrics Sciences, University of Washington, Seattle WA

Murdoch Children‚Äôs Research Institute, Royal Children‚Äôs Hospital, Melbourne, Australia

¬ß

Corresponding Author

Background: The epidemiology of COVID-19 remains speculative in Africa. To the best of our knowledge, no
study, using robust methodology provides its trajectory for the region or accounts for local context. This paper is
the first systematic attempt to provide prevalence, incidence, and mortality estimates across Africa.
Methods: Caseloads and incidence forecasts are from a co-variate-based instrumental variable regression model.
Fatality rates from Italy and China were applied to generate mortality estimates after making relevant health
system and population-level characteristics related adjustments between each of the African countries.
Results: By June 30 2020, around 16.3 million people in Africa will contract COVID-19 (95% CI 718,403 to
98,358,799). Northern and Eastern Africa will be the most and least affected areas. Cumulative cases by June 30
are expected to reach around 2.9 million (95% CI 465,028 to 18,286,358) in Southern Africa, 2.8 million (95% CI
517,489 to 15,056,314) in Western Africa, and 1.2 million (95% CI 229,111 to 6,138,692) in Central Africa.
Incidence for the month of April 2020 is expected to be highest in Djibouti, 32.8 per 1000 (95% CI 6.25 to 171.77),
while Morocco will experience among the highest fatalities (1,045 deaths, 95% CI 167 to 6,547).
Conclusion: Less urbanized countries with low levels of socio-economic development (hence least connected to the
world), are likely to register lower and slower transmissions at the early stages of an epidemic. However, the same
enabling factors that worked for their benefit can hinder interventions that have lessened the impact of COVID19 elsewhere.

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

1

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

I.

doi: https://doi.org/10.1101/2020.04.09.20059154

INTRODUCTION

The novel human coronavirus (SARS-CoV-2 or COVID-19) outbreak initially emerged in Wuhan,
China, in late 2019. Since then, it has spread to 198 countries and territories around the world and has
been declared a pandemic. (1) As of March 31, 2020, there have been 750,874 reported COVID-19 cases,
with 36,045 deaths, and 117,603 recoveries. (1) The first confirmed COVID-19 case in Africa was
reported in Egypt on February 14, 2020 and since then the number of confirmed infections in the region
has surpassed 5,000 cases as of March 31, 2020. (2-3) Comoros, Lesotho, Malawi, and South Sudan are
the only African countries that have not reported a confirmed case as of March 31, 2020.
To date, no vaccine or effective treatment is available for COVID-19. Therefore, the ability to minimise
the devastating consequences of the disease on people‚Äôs lives and livelihoods relies on the implementation
of effective preventative non-pharmaceutical interventions (NPIs). NPIs include multiple public health
measures designed to reduce viral transmission rates in a population by reducing the reproduction
number (R0); the average number of secondary cases each case generates. (4-6)
NPIs directly influence the course of the COVID-19 pandemic, including the rate of spread, and the
expected duration of the pandemic. However, several characteristics of the virus remain ambiguous or
mostly unknown, (7-8) such as the incubation period (the time between infection and symptom onset),
serial interval (the time between symptom onset of a primary and secondary case) the extent of
asymptomatic cases, the possibility of pre-symptomatic infectiousness, case fatality rate (CFR), and
also the possible role of weather in transmission. Estimates for COVID-19 CFR range from 0.3-1%. (9)
Asymptomatic or mild presentation comprises the bulk of the reported cases, which is an estimated at
80%. (10) Longitudinal viremia measurements from a small study (sample size of 16), suggests that
there are high enough viral loads to trigger pre-symptomatic infectiousness for 1-2 days before the onset
of symptoms.(11) With the lack of clinical studies measuring viremia, the infectious period also remains
largely unknown, with estimates ranging from few days to 10 days or more after the incubation period.
(11)
The complexity of the infection and recovery process, therefore, means that proper understanding of
the epidemiological dynamics of COVID-19 within the local context is fundamental to combat the
pandemic. Studies illustrating future trajectories of the disease are not only helpful to develop early
warning systems, avoid overwhelming healthcare services and minimize morbidity and mortality from
the disease, but also assist countries to evaluate the effects of interventions and the long-term
consequences of the virus on peoples‚Äô livelihood. This is particularly true in Africa, where livelihoods
are fragile, and previous epidemics, such as HIV/AIDS and, more recently, Ebola, have been known to
exert enormous socioeconomic consequences. (12-14) In addition, in the face of a new pandemic in the
region, the already overstretched healthcare systems that are struggling to deliver essential healthcare
services such as immunization and HIV/AIDS treatment would be in further jeopardy and at risk of
losing the gains achieved so far in disease control efforts. This study, using a robust methodology,
provides spatial and temporal trajectories of COVID-19 for the entire Africa region. To the best of our
knowledge, this is the first such attempt and accounts for the local context and characteristics relevant
to the epidemiology of the diseases in the region.
The remainder of this paper is divided into three sections. In section 2, we describe our covariate based
predictive model and the input data that has been used in the modeling exercise. We also describe the
methodology used for estimating deaths from COVID-19. Section 3 provides the results on the projected
new infections, cumulative cases, and deaths due to COVID-19 across several countries, covering the
five sub regions. Finally, we discuss the key findings and implications of the study in section 4 and in
Section 5 provide some concluding remarks.

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

2

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

II.

doi: https://doi.org/10.1101/2020.04.09.20059154

METHODS

The analysis is based on a linear instrumental variable (IV) regression framework. The basic model
consists of two equations which can be expressed as follows: (15-17)

Y = Œ¥ + Œ≤1 K + Œ≤2 X + u i
K = Œ∏ + Œ±1T + zi
‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶.Equation (1)
Here, Y represents the number of confirmed cases of COVD-19 for each country as of March 31, 2020.
K is the rate of infection between week 1 and week 2 of the epidemic in the country and is an endogenous
variable. T and X represent a set of instrumental and exogenous variables, respectively. ui and zi are
error terms and both are assumed to have a zero mean and a nonzero-correlation. (18-20) Œ¥, Œ∏, Œ±, Œ≤ are
regression coefficients to be estimated from the model.
The model captures a combination of epidemiological, socio-economic and health system readiness
related covariates. On the epidemiological side, it includes time since the introduction of the virus
measured against March 31 2020, the rate of its expansion between week one and week two of the
pandemic in the respective countries as well as the disease profile of each nation. We have modeled the
‚Äòearly expansion factor‚Äô using air traffic as its instrument because the early stage of the epidemic is
presumed to be dominated by imported cases rather than due to community infection. Wooldridge‚Äôs
(1995) robust score test for endogeneity has confirmed our expectation that the rate of early expansion
must be treated as endogenous.
We have also included in our model household size and age structure because both can influence social
distancing behavior and practices and could play a mediating role once a community infection is in
place. Urbanization and living standard can be expected to further serve as fertile grounds for spreading
viruses widely as they could facilitate the interaction and flow of people across a wider environment.
Likewise, countries that adhere to international health regulations and provide better access to quality
health care are likely to detect and report cases better.
Taking these hypothesized relationships in to account, we have captured the following covariates in our
model: time since first reported case, rate of expansion of the disease between week one and week two
of the epidemic, urbanicity, socio-demographic index (as a measure of living standard), average
household size, the age structure of the population, health care access and quality index, adherence to
international health regulations, and prevalence of HIV and asthma.
The data on prevalence of HIV and asthma, as well as on socio-demographic index and the index of
health care access and quality, were from Institute of Health Metrics and Evaluation (IHME). (21-23)
The data on urbanization were obtained from the Population Reference Bureau, (24) while average
household size, age profile, and data on the total population used for the calculation of rates were all
from the UN Population Division. (25) The index of adherence to international health regulations was
accessed from the World Health Organization (WHO), while the number of confirmed cases was from
the John Hopkins database of COVID-19. (26 -27)
The 11 variables selected for analyses were chosen out of an initial set of over 20 variables that included
the proportion of households with at least one member aged 60 years or over, the proportion of
households with at least one member aged 65 years or over, the World Bank‚Äôs governance index, as
well as the prevalence of TB, diabetes and malaria. STATA‚Äôs Lasso software for model selection was
used to narrow down the list of covariates. (28) Furthermore, out of the global database covering the
193 countries that we captured as an input in our analyses, for a few countries, data were unavailable
¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

3

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

for selected variables, namely air traffic (25 countries), adherence to international health regulation (20
countries), and household size (24 countries). To bridge the gap, we performed multiple imputation
procedures, particularly by running 1000 imputations and 99 000 iterations using STATA‚Äôs multiple
imputation routine. (29-30) The resulting median values from the imputation exercise were
subsequently used to estimate the prediction model specified earlier. We transformed all the regressors
as well as the dependent variables to a log-scale before they were put into the model.
The goodness-of-fit for the predictive model was evaluated using k-fold cross-validation technique. (3132) The advantage of a k-fold cross-validation technique over other statistical validation procedures is
that all observations are used for both training and validation, and each observation is used for
validation exactly once. (31) When summarized, our prediction results can be viewed as a function of
time since the introduction of the virus, once those other time-invariant covariates are controlled for.
Higher order relationships with time are not considered here because the pandemic in the Africa region
is in early and expansionary stage. As more and more countries in the world manage to ‚Äòflatten the
curve‚Äô the trends and lessons from those experiences can be integrated in covariate-based models like
ours.
Estimation of COVID-19 deaths was made using an approach that loosely related to indirect
standardization technique, with additional adjustments for differences in health system readiness and
living standards. In the absence of age-specific infection data the proposed approach can be expressed
in a general form as follows (including in instances where age is treated as a continuous function):

ùëéùë¶ùëò = [ùëùùë¶ ‚à´ ùë§ùëñùë¶ ùëêùëñùëò ]‚ÅÑùëèùë¶ùëò ‚Ä¶.‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶. (Equation 2a)
Where,

ùëèùë¶ùëò = ‚àöùëÜùë¶ ùëÑùë¶ / ‚àöùëÜùëò ùëÑùëò ‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶‚Ä¶(Equation 2b)

Here, ùëéùë¶ùëò is the estimated number of deaths for country y (y= 1, 2‚Ä¶47) using country k‚Äôs (China and
Italy) COVID-19 fatality rate, general health system readiness and socio-economic standards as a
reference. ùëêùëñùëò is the standard or reference age-specific fatality rate for age group i in standard country
k, in our case obtained from China and Italy. ùë§ùëñùë¶ is the population at age i in country y; ùëùùë¶ is
population level COVID-19 prevalence rate and is an estimate we generated using the instrumental
variable regression expressed in equation 1. The quantity in the square bracket represents agestandardized estimated number of deaths in country y, if age-specific fatality rates were to follow those
of the standard populations. However, our study population differs from the two countries not just with
respect to age structure but also living standard and health system readiness. Hence, to adjust the
estimated deaths further we developed a correction factor that links the socio-economic status and
health system readiness of each country with those two populations, which is represented by ùëèùë¶ùëò . In
this case, ùëèùë¶ùëò is a geometric-mean of the socio-demographic index (S) and the health access and quality
index (Q) relative to that of country k. The relevant data for each country was sourced from IHME.
(21-22) Analysis was performed using STATA version 16.0 .(33)

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

4

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

III.

doi: https://doi.org/10.1101/2020.04.09.20059154

RESULTS

Figure A1 in the Appendix shows a graphical comparison of observed and predicted confirmed COVID19 cases (on the log scale). Table A1 presents results from the cross-fold robustness test for the
predictive model. The statistical diagnostic tests as well the patterns from the graphical analysis suggest
that the predicative model sufficiently captures the observed data. As can be seen from the table, not
only are the RMSE, the MAE and the Pseudo-R2 consistent across samples, the error margins are also
small. Hence, we have used the resulting model to forecast cumulative COVID-19 cases, estimate new
infections and deaths from COVID-19 for each of the 47 African countries which have reported at least
one case as of March 31, 2020.
Cumulative COVID-19 cases and point prevalence rates
Table 1 presents cumulative COVID-19 cases and prevalence rates for Africa and its five sub-regions
for the period April 1 to June 30 2020. By the end of April cumulated infection across the region will
reach 2.5 million cases and will further increase to 16.2 million by June 30. During the same period,
cumulative cases in the hardest hit sub-region in the African continent, Northern Africa, is predicted
to increase from 1.3 million at the end of April to over 7.5 million by June 30. This is followed by
Southern, Western, and Central Africa sub-regions. Throughout the forecast period, Eastern Africa is
predicted to experience the lowest case load and prevalence rate in the continent throughout the forecast
period. Note these estimates are highly uncertain; the 95% confidence intervals (CI) are shown in Table
1 below.
Table 1: Cumulative cases and prevalence rates for COVID-19, Africa: April 1 ‚Äì June 30, 2020.
Panel A: Cumulative number of infected people at end of reported month; Forecast, April 1 ‚Äì June 30
March
Point estimate
Lower bound (95% C.I)
Sub-region
31st
Reported

Upper bound (95% C.I)

April

May

June

April

May

June

April

May

June

Central

155

179,089

599,906

1,185,742

35,748

117,282

229,111

897,478

3,069,555

6,138,692

Eastern

375

136,933

458,692

906,625

27,122

88,980

173,821

693416

2371620

4,742,917

Northern

2454

1,282,284

4,295,345

8,489,940

207,982

682,342

1,332,953

7914479

27069102

54,134,517

Southern

1385

439,947

1,473,716

2,912,864

72,559

238,049

465,028

2673470

9143801

18,286,358

Western

1259

421,075

1,410,499

2,787,913

80,744

264,904

517,489

2201237

7528670

15,056,314

Africa

5628

2,459,328

8,238,158

16,283,084

424,155

1,391,557

2,718,402

14,380,080

49,182,748

98,358,798

Panel B: cumulative infection rate (point prevalence, %): Forecast, April 1 ‚Äì June 30, 2020
Point estimate

Sub-region

Lower bound (95% C.I)

Upper bound (95% C.I)

April

May

June

April

May

June

April

May

June

Western

0.13
0.03
0.52
0.53
0.10

0.44
0.11
1.75
1.78
0.32

0.87
0.23
3.46
3.52
0.63

0.03
0.01
0.09
0.09
0.02

0.09
0.02
0.28
0.29
0.06

0.17
0.04
0.54
0.56
0.12

0.66
0.17
3.24
3.23
0.50

2.26
0.59
11.06
11.05
1.70

4.51
1.18
22.09
22.07
3.39

Africa

0.19

0.63

1.24

0.03

0.11

0.21

1.10

3.76

7.51

Central
Eastern
Northern
Southern

Figure 1A shows spatial patterns of cumulative COVID-19 cases for the African continent. In Northern
Africa, the leading contributor to the burden of COVID-19 is Morocco. By the end of June, Morocco
will have 4.5 million cumulative COVID-19 cases, and this is almost double the estimated number for
Algeria, a country with the next highest burden, 2.8 by the end of June. In Southern Africa, South
¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

5

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

Africa and Swaziland are on the lead. By the end of June, these two countries are expected to have
respectively around 2.6 million and 250 thousand cumulative COVID-19 cases. In the Western Africa
sub-region, cumulative cases will be dominated by Cote d‚ÄôIvoire and Ghana, despite Nigeria having a
larger population than both countries combined.
To remove the effect of size, we also estimated prevalence rates shown in Panel B of Table 1 by
combining the forecasts on cumulative cases with population estimates which we generated for each
month from the UN annual population estimates. This suggests that population level prevalence of
COVID-19 in Africa is expected to remain under 1.5 percent (CI 95% 0.03 to 7.6) throughout the
prediction period, but there are wide inter-regional differences. In the Northern and Southern Africa
sub-regions, cumulative infection rates are expected to be slightly over 3 percent, with the rate in the
respective subregions expected to be around 3.5 percent (CI 95% 0.09 to 22.1) as of June 30. This
means that even under a very high infection scenario, as observed in the 95% upper confidence interval
for the two sub-regions, infection rates are unlikely to reach more than a quarter of the continent‚Äôs
population.

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

6

MedRxiv: Africa and the COVID-19 pandemic

Figure 1 (a) Cumulated COVID cases June 30, 2020; (b)

doi: https://doi.org/10.1101/2020.04.09.20059154

COVID-19 incidence per 1000 population April 2020, and (c) Number of COVID-19 deaths April 2020

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

7

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

New infections and COVID-19 incidence rates across Africa
Across the months, the number of new COVID-19 infections are expected to increase from 2.5 million
cases in April, to 5.8 million cases in May, to 8 million cases by the end of June. This represents a 135%
increase from April to May and a 39% increase from May to June, which suggests a possible slowing
down of the pandemic over time.
Table 2: Number of new infections and incidence rates for COVID-19, Africa: April 1 ‚Äì June 30, 2020.
Panel A: Number of new infection at end of reported month; Forecast, April 1 ‚Äì June 30
Point estimate

Sub-region

Central
Eastern

Lower bound (95% C.I)

Upper bound (95% C.I)

April

May

June

April

May

June

April

May

June

178,934

420,817

585,835

35,593

81,534

111,829

897,323

2,172,077

3,069,137

136,558

321,759

447,933

26,747

61,858

84,842

693,041

1,678,204

2,371,297

Northern

1,279,830

3,013,060

4,194,595

205,528

474,360

650,611

7,912,025

19,154,623

27,065,415

Southern

438,562

1,033,769

1,439,149

71,174

165,490

226,979

2,672,085

6,470,331

9,142,557

Western

419,816

989,424

1,377,415

79,485

184,160

252,585

2,199,978

5,327,433

7,527,645

2,453,700

5,778,830

8, 044,927

418,527

967,402

1,326,846

14,374,452

34,802,668

49,176,051

Africa

Panel B: New infection in each month (incidence rate, %): Forecast, April 1 ‚Äì June 30, 2020
Point estimate

Sub-region

Lower bound (95% C.I)

Upper bound (95% C.I)

April

May

June

April

May

June

April

May

June

Western

0.13
0.03
0.52
0.53
0.10

0.31
0.08
1.23
1.25
0.22

0.43
0.11
1.71
1.74
0.31

0.03
0.01
0.08
0.09
0.02

0.06
0.02
0.19
0.20
0.04

0.08
0.02
0.27
0.27
0.06

0.66
0.17
3.24
3.23
0.50

1.60
0.42
7.83
7.82
1.20

2.25
0.59
11.04
11.03
1.70

Africa

0.19

0.44

0.61

0.03

0.07

0.10

1.10

2.66

3.76

Central
Eastern
Northern
Southern

Sub-regional and country level differences are expected to deepen as the pandemic becomes more
established in the region. In the coming three months, incidence is expected to increase faster in
Southern and Northern Africa, followed by the Central Africa sub-region. In each sub-region, we expect
some countries to be affected more than others and become hotbeds of new infections (see Figure 1B).
In places like Djibouti, the rate of new infections is expected to reach as high as 32.8 (CI 95% of 6.25
to 171.77) cases per 1000 population, followed by Swaziland with a rate of new infection of 26.8 (CI
95% of 4.97 to 144.39), Morocco with 11.97 (CI 95% of 1.98 to 71.59), Algeria with 9.80 (CI 95% of
1.57 to 60.72) and Cote d‚ÄôIvorie with 6.65 (CI 95% of 1.07 to 29.68). See Figure 1B.

Estimated COVID-19 mortality
Deaths for COVID-19 are estimated for each country, using the approach described in Section 2. As
can be seen in Figure 2, the adjustment shows relatively higher expected mortality using Italy as a
standard compared to China, but generally are closer to each other. Hence, our final country level
estimates presented in Figure 1C and the regional summaries in Table 3, were generated using the
arithmetic mean of death numbers generated using the two standard populations.

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

8

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

Figure 2: Comparison of estimated number of deaths using China and Italy as standard, April 2020.

Table 3: Estimated number of COVID-19 deaths, April- June 2020
Point estimate
April
May
June

Lower bound (95% C.I)
April
May
June

Upper bound (95% C.I)
April
May
June

Central

248

828

1632

49

162

316

1,241

4,234

8,445

Eastern

141

473

933

28

92

180

712

2430

4851

Northern

1,836

6,144

12,131

297

1,032

2,014

11,354

38,792

7,7497

Southern

468

1566

3092

77

262

512

2,856

9,757

19,494

Western

445

1489

2936

86

278

543

2,319

7,915

15,797

3,138

10,499

20,723

537

1,827

3,564

18,482

63,128

126,084

Africa

The first COVID-19 case in Africa was reported on February 14, 2020 (2, 3). Two months after the
first COVID-19 cases were reported in the region, the number of deaths at the end of April is expected
to reach over 3,000 deaths (CI 95% of 537 to 18,482). Most deaths will be recorded in the Northern
Africa sub-region, which, as reported earlier, also had the largest number of COVID-19 cases and the
highest prevalence and incidence rates of all sub-regions in the content. Southern and Western Africa
are expected to experience a comparable death toll, while deaths in the Eastern Africa sub-region are
expected to be the lowest of the sub-regions in Africa. Some countries such as Algeria, Morocco and
South Africa are expected to experience the highest number of casualties since the beginning of the
pandemic, in excess of 400 deaths. Deaths in the three countries will comprise of almost two-thirds of
all expected deaths in the region. In others, such as the Democratic Republic of Congo, Tunisia and
Cote d I‚Äôvorie, the death toll will reach between 150 and 300, and contribute 20% to the regional total,
while half of the continent (about 29 countries) will experience less than 10 deaths each. The same
trend continues in May and June, but with a much higher number of expected deaths.
¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

9

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

IV.

doi: https://doi.org/10.1101/2020.04.09.20059154

DISCUSSION

The COVID-19 pandemic has been spreading rapidly across different parts of the world and the African
continent has not been spared. Given the global trajectory, what lies ahead in terms of the course and
magnitude of infection in Africa in the days and months to come remains speculative. While there have
been attempts elsewhere in capturing the trajectory of the COVID-19 pandemic using agent-based, or
mathematical, and or statistical models, this has not been the case for the African region as whole. (46, 8) To the best of our knowledge, no study, using a robust methodology, provides estimates on future
trend of COVID-19 for the entire region or accounts for its local context.
Modeling and predicting the epidemiology and trajectory of a disease such as COVID-19 is a challenging
exercise. Firstly, COVID-19 is a newly identified pathogen and knowledge about the characteristics of
the virus, including how the disease is spread and the time from exposure to onset of symptoms are
still evolving. Secondly, at the time of writing, less than a handful of countries had reached a plateau
in their infection rate, and this makes modeling future trends an open-ended exercise. (1) The fact that
some people only experience mild symptoms and that even the best health system can only detect and
treat those presenting to facilities also means that the available data on ‚Äòconfirmed‚Äô cases represents
only a fraction of the true picture of the pandemic.
Thirdly, literature on the association between disease prevalence and population level characteristics
that are known to be the staple of social and descriptive epidemiology, and the backbone of predictive
modeling exercises are yet to emerge for COVID-19. (4-6, 8) Further, at the individual level, knowledge
on the determinants of COVID-19 morbidity and mortality is limited to selected characteristics such
as age and pre-existing conditions, and even then, they are drawn from scanty data. The association
with community and population level characteristics is even more limited, hence largely speculative. In
this context, the task of developing a multi-country covariate-based predictive model for COVID-19 in
any country or region of the world, let alone Africa, is likely to be guided by what is feasible, and to
the extent, the available data permits it. It also means that there is a need for constant revision of
predictive models as new data becomes available. In our case, the work is further complicated because
in Africa data on key covariates are either lacking or when they exist, they tend to be biased or derived
from other global covariate-based modeling exercises. (21-22)
Despite this, we have made efforts to mitigate these limitations by curating data from various credible
sources around the world and assessing them for consistency. In developing our model, we have used
data sources from 193 countries globally and used statistical relationships to fill data gaps on covariates
in the Africa region. Additionally, our model performance was assessed through rigorous out of sample
calibration using k-fold cross-validation techniques and obtaining robust results. We have also restricted
our forecast to the first few months (April-June) and refrained from a long-term projection exercise.
Firstly, this is because we anticipate new and additional data to emerge in the short term that will lead
to better and improved estimates. Secondly, where data is sparse, any long-term projection is more
likely to be detached from reality and can easily become a wild guess and is therefore less useful for
informing policy actions. Thirdly, if the countries in the region will not be able to put effective strategies
soon (or in those who have already initiated them render to be ineffective), the extent and consequence
of COVID-19 on the continent would be greater than any predictive model could anticipate.
Within these caveats, our study substantially contributes to the growing literature on understanding
the trajectory of the COVID-19 pandemic. This perspective is particularly important for Africa at a
time of controlling a pandemic given that Africa the region is home to over 1.3 billion people. (34) In
addition, as the COVID-19 pandemic is predicted to start to taper off in the northern hemisphere there
are increasing concerns and attention towards Africa and elsewhere in the southern hemisphere that
had late introduction and slow uptick of cases. Our model projection is therefore necessary, and timely
to guide this attention.

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

10

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

Our results show a heterogeneous picture of projected new infections, cumulative cases, and deaths
across the African continent. Our Among our key findings are that African countries that are relatively
more urbanized and have a higher socio-demographic index (SDI) are projected to experience a faster
growth of the epidemic, at least during the initial periods. To illustrate this trend, Algeria, Morocco,
and Tunisia, in the Northern African sub-region, which have a predominantly urban population, and
are in close proximity to the high burden European countries, are projected to experience a higher
incidence of COVID-19 infections in comparison to their neighbors. In the Southern Africa sub-region,
South Africa, which has a proportionately higher urban population and greater international
connectivity, is also projected to lead the rest of the pack in terms of new infections rates. In the Eastern
Africa sub-region, Kenya, which is relatively more urbanized has a higher per capita incidence rate in
comparison to other countries within the sub-region. However, it is noted that some of these countries
also have higher living standards and better health system than most countries in the region. Hence
the high prevalence rates and estimated deaths in these countries may in part reflect their greater
ability to detect and confirm COVID-19 cases.
On the other hand, countries such as Angola, Botswana and Mozambique with a lower international
connectivity are projected to have lower rates of new infections during the initial periods. Similar trends
are observed in Burundi and Tanzania in the Eastern Africa region. However, as the epidemic grows
many of these countries are projected to experience increases in cumulative infections that are likely to
overwhelm their health system. Overall, these trends are consistent with other regions of the world,
where since the onset of this pandemic, it has been clear that higher connectivity, particularly through
air traffic, and higher population densities are key drivers in the introduction and growth of the
epidemic. (35-39)
The impact of population density is clearly illustrated by the projected new infections of COVID-19 in
places like Djibouti and Rwanda. To compound this, close to 90% of urban settlements in Africa are
comprised of informal settlements, most of which are overcrowded and lack basic amenities such as
clean water and sanitation which are critical prevention measures for COVID-19. (40-42) Moreover,
60% of jobs in urban areas are in the informal economy, (43) and if African countries were to implement
stringent lockdowns these livelihoods would be largely affected and could lead to significant
socioeconomic consequences. For instance, those that lose their jobs are likely to move back to their
homes in rural areas, where many of the elderly population reside, hence putting them at risk. Similarly,
as the economy slows down in several countries due to the COVID-19 pandemic, some sections of
migrant workers from African countries might be forced to return to their home countries and hence
further complicating the dynamics of the pandemic.
Therefore, large scale measures that are aimed at limiting population movement, across countries as
well as increasing the social distance among populations, are not enough, or at best may prove to be
impractical to address the pandemic in the African context. Comprehensive response measures should
be contextualized and seek to address some of the underlying individual and structural factors that are
likely to complicate the epidemic within these environments. It is crucial to balance interventions geared
towards preventing the spread of the epidemic with the need to maintaining livelihoods and social
cohesion. Measures such as appropriate messaging, provision of adequate water and sanitation
subsidies, food as well as targeted restriction of movement (e.g. from urban to rural) would go a long
way to mitigate the spread.
Still, even with all these NPI measures, several countries with weak healthcare delivery systems are
expected to have a significant number of infections and fatalities. Therefore, the already overstretched
healthcare systems in Africa need to anticipate and prepare to handle an increased number of patients
as a consequence of the pandemic, on top of the other common disease conditions that are prevalent in
the region. Unfortunately, this is a lesson Africa has already had to learn from the 2014 Ebola outbreak
in West Africa. It is estimated there were an additional 11,000 deaths from malaria, HIV/AIDS and
TB across Sierra-Leone, Guinea and Liberia, (44) a 60% decrease in the number of children treated for
¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

11

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

diarrhea and acute respiratory infections (45) and a 38% increase in maternal mortality in Guinea and
a 111% increase in Liberia. (46-47)
Understanding the factors that accelerate and those that mitigate the spread and mortality related to
COVID-19, while accounting for local realities, is fundamental for sound public health measures to
tackle the pandemic. In fact, lessons from HIV/AIDS programming have taught us that highly effective
health interventions fail if the local context is not recognized. Therefore, decision makers in Africa must
realize that one size does not fit all and could lead to disastrous outcomes. They should also find ways
and means to maintain the progress made toward universal childhood immunization and the HIV
epidemics in the region.
Effective detection and response to epidemics is premised on decision makers having the right
epidemiological information. Unfortunately, many countries in Africa have weak health information
systems that are not able to collect and process data rapidly to facilitate timely and targeted action.
For example, Lesotho, despite being in the same region and with closer proximity to South Africa and
Swaziland, countries that are at the epicentre of the COVID-19 pandemic in the Southern Africa subregion, is yet to register a confirmed case. This is a clear example of the gap in diagnostic capacity and
health information system rather than the absence of infection in the country. Hence, the fight to stop
the pandemic in Africa should be focused on both strengthening clinical capacity as well reporting
systems within the health care system. Innovations around collecting data through digital platforms
make it easier to combine different data streams, thereby helping decision-makers gain a better
understanding of epidemics and the impact of the interventions. (48-52) With close to 747 million SIM
connections in Sub-Saharan Africa, representing 74% of the population on the continent, (53) the
response to the COVID-19 pandemic provides an opportunity for countries to retool their data collection
systems to meet their surveillance needs.
In addition, the mobile digital technologies could enable confidential self-reporting of symptoms to
healthcare providers‚Äô, catalyzing further investigation and epidemic control measures before it spreads
beyond defined population subgroups. As an information and health communication tool, mobile
platforms could also be leveraged to deliver appropriate health messages to the population, relieving
direct consultation pressure from health system providers.
Efficient resource allocation and use is only feasible where there is improved visibility across the various
components of the health system through high quality health information systems. (54) Ideally, this
should cover key areas such as human resources for health, infrastructure and equipment, medicines
and other health commodities, and financial resources available. This is particularly needed in epidemic
situations, where there are often huge distortions in demand for resources, that if not well addressed
could lead to wastage and suboptimal population health outcomes.
Lastly, but equally important in the African context, the global health community and governments
addressing the COVID-19 pandemic should be inclusive in their efforts because the efficacy of a response
to any emergency is only as good as its weakest link. It is therefore important that governments include
marginalized communities, such as refugees, migrants and internally displaced populations (IDPs) in
their policies and actions. Across Africa, approximately 12.3 million people remain forcibly displaced,
including 8.1 million internally displaced people and 4.2 million refugees. (55) Moreover, Sub-Saharan
Africa alone hosts more than 26% of the world‚Äôs refugee population. (56- 57) These populations are
likely to face a different set of constraints that restricts their ability to prevent themselves from getting
infected and accessing health care. The fact that they also live in under difficult circumstances means
that governments across the region should maintain critical supply corridors for humanitarian assistance
and address the needs of the most vulnerable within their borders. In the longer term this pandemic
should also be a call for African governments to further strengthen engagement with international
humanitarian actors in order to foster strong partnership building on local capacities. Within this supranational context, the issue of ‚Äòlivelihood corridor‚Äô also needs to be looked at carefully and more broadly,
given that AfCFTA (the African Continental Free Trade Agreement) which is expected to govern trade
¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

12

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

and flow of goods and services in the region will come into effect on July 1 2020 (African Union 2020).
Hence, current and planned NPIs in the region need to consider such regional initiatives to ensure that
responses to the pandemic at country and regional level are coherent and able to balance saving the
lives and livelihood of the people of the African continent.

V.

CONCLUSIONS

It is true that some of the most successful responses to global health threats including recent ones like
Ebola and HIV/AIDS have been characterized by multi-stakeholder partnerships. African health
systems have been in the forefront in the implementation of such programs and would be best served
to leverage that experience and resources in responding to COVID-19. Bringing all stakeholders
together to ensure effective coordination, pooling of resources and delivery of evidence-based
interventions is imperative for any sustainable response to such pandemic situations.
Within, the African context, policy makers should also consider (a) impact of strategies that could
potentially deepen health inequalities and (b) continuously use data driven approaches to identifying
their unique most at risk/vulnerable groups e.g. IDP, HIV positive, food insecure to support them in
an equitable manner and bring them into the COVID-19 prevention framework. At a time of a
pandemic no one community can be marginalized.
Finally, in as much as health systems are dealing with an emerging situation, measurement is a
fundamental tool to guide strategic response actions. The measurement framework should be agile yet
comprehensive, rather than being piecemeal. It should seek to combine data from multiple sources
within the healthcare system into a joint assessment framework such that a consistent and informative
narrative emerges to tackle the epidemic. The age-old call for accurate health metrics to address
population health still remains valid. Our best estimates presented in the paper are a forecast, and their
ability to capture reality is as good as the underlying data. It is thus imperative to review the model
and the results as new data becomes available and update the estimates accordingly.
CONFLICTS OF INTEREST
Abaleng Lesego (AL), Flavia Senkubuge (FS), Lawrence Were (LW), Richard G Wamai (RGW),
Shuangzhe Lie (SL), Tesfaye Gebremedhin (TG), Tom Achoki (TA), Uzma Alam (UA) and Yohannes
Kinfu (YK) report no conflicts of interest.
AUTHORS CONTRIBUTIONS
YK conceptualised the study, designed methods and approach; guided the statistical analysis and
drafted the manuscript. UA synthesised the literature, contributed to conceptualisation and drafted the
manuscript. TA accessed data, contributed to methods and design, undertook the statistical analysis
and drafted the manuscript. LW, TG, FS, AL SL, and RGW reviewed the draft and contributed to
the scientific content of the manuscript. All authors contributed to the discussion, read and approved
the final draft.
ACKNOWLEDGMENTS
This study was finalised when YK was in a government designated quarantine centre for COVID-19 at
Sydney InterContinental Hotel, upon his return to Australia. YK would like to acknowledge the
Commonwealth Government of Australia and the New South Wales Government for supporting his
stay at the hotel free of charge and creating an environment that enabled him to continue with his
research and teaching activities, while doing their part to combat COVID-19.
FUNDING
¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

13

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

No direct funding was solicited for the study
PATIENT AND PUBLIC INVOLVMENT STATEMENT
Patients or the public WERE NOT involved in the design, or conduct, or reporting, or dissemination
plans of our research.
ETHICAL APPROVAL
Analyses was undertake using publicly available secondary data, hence no ethics approval was sought.

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

14

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

REFERENCES
1.
2.
3.
4.

5.

6.

7.

8.
9.

10.
11.
12.

13.

14.
15.
16.

WHO WHO COVID-19 data accessed April 3 2020
African CDC https://africacdc.org/covid-19/ accessed April 2 2020
WHO EMRO http://www.emro.who.int/index.html accessed April 6 2020
Ferguson N.M, Laydon. D, Nedjati-Gilani. G, Imai.N, Ainslie.K, Baguelin.M, Bhatia.S,
Boonyasiri.A et.al., Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19
mortality and healthcare demand. London: Imperial College COVID-19 Response Team,
March 16 (2020). Imperial College accessed March 23 2020
Tian. H, Liu. Y, Wu.C, Chen. B, Kraemer. M et.al, Early evaluation of transmission control
measures in response to the 2019 novel coronavirus outbreak in China.
https://www.medrxiv.org/content/10.1101/2020.01.30.20019844v4
Murray. C. JL, IHME COVID-19 health service utilization forecasting team. Forecasting
COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in
the next 4 months medRxiv 2020.03.27.20043752;
https://doi.org/10.1101/2020.03.27.20043752
WHO. Coronavirus disease (COVID2019) situation report-30.
https://www.who.int/docs/defaultsource/coronaviruses/situation reports/20200219sitrep30covid19.pdf?sfvrsn=3346b04f_2 accessed March 31 2020
Martinez-Alvarez.M, Jarde.A, Usuf.E, Brotherton.H, Bittaye.M, Samateh Al, Antonio. M
et.al., COVID-19 pandemic in West Africa Lancet Glob Health 2020, April 1, 2020
Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country- based
mitigation measures influence the course of the COVID-19 epidemic? Lancet. Comment|
Volume 395, ISSUE 10228, P931-934, March 21, 2020
European Centre for Disease Prevention and Control. Daily risk assessment on COVID19
https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea accessed April 2 2020
Zou L Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, et.al., SARSCoV2 viral load in
upper respiratory specimens of infected patients. N Engl J Med 2020; 382:1177-1179
Kinfu. Y, Opiyo.C, & Wamukoya, M. (2014). Child Health and Mortality in sub-Saharan
Africa: Trends, causes, and forecasts. In C. O. Odimegwu, & J. Kekovole (Eds.), Continuity
and change in sub-saharan African Demography (Vol. 17, pp. 60-77). (Routledge African
Studies; Vol. 17). New York, USA: Routledge https://doi.org/10.4324/9781315879444
Kastelic. K, Himelein. T, Mauro.T, Abubakarr. T,. The socio-economic impacts of Ebola in
Sierra Leone : results from a high frequency cell phone survey (round three) (English).
Washington, D.C: World Bank Group.
http://documents.worldbank.org/curated/en/873321467999676330/The-socio-economicimpacts-of-Ebola-in-Sierra-Leone-results-from-a-high-frequency-cell-phone-survey-round-three
accessed March 22 2020
Wooldridge. J 2010 Econometric Analysis of cross section and panel data. 2nd ed. Cambridge,
MA: MIT press
Cameron A.C and Trivedi P.K. 2010 Micro econometrics using Stata. Rev ed College Station,
TX: Stata Press
Davidson R and Mackinnon J.G. 1993 Estimation and inference in econometrics New York:
Oxford University press

17. Martens. E.P, Pestman. W.R, De Boer. A, Belitser. S.V, & Klungel O.H. (2006). Instrumental
Variables: Application and Limitations. Epidemiology, 17(3), 260-267
18. Cameron A.C and Trivedi P.K. 2005 Microeconometrics methods and applications New York:
Cambridge University press
19. Greene. WH 2018 Econometric Analysis 8th ed. New York: Pearson
20. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2015
(GBD 2015) Socio-Demographic Index (SDI) 1980‚Äì2015. Seattle, United States: Institute for
¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

15

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

Health Metrics and Evaluation (IHME), 2016.
21. GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the
Healthcare Access and Quality Index for 195 countries and territories and selected
subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.
Lancet. 2018 Jun 2;391(10136):2236-2271.
22. Global health data exchange http://ghdx.healthdata.org/ accessed March 24 2020
23. Population reference bureau https://www.prb.org/data/ accessed March 24 2020
24. UN Population division https://www.un.org accessed March 25 2020
25. WHO Health Statistics https://www.who.int/healthinfo/statistics/en/ accessed March 22
2020
26. Johns Hopkins Coronavirus resource center https://coronavirus.jhu.edu/data accessed March
31 2020
27. Lasso Reference Manual, Release 16 College Station, TX: Stata Press.
28. Rubin. D.B Multiple imputation for non-response in surveys 1987. New York: Wiley
29. Schafer. J.L Analysis on incomplete multivariate data. 1997. Boca Raton Fl. Chapman
&Hall/ CRC
30. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning: data mining,
inference, and prediction. 2nd ed. New York, NY: Springer; 2009. 219-260
31. Rao C, Adair T, Kinfu Y. Using historical vital statistics to predict the distribution of underfive mortality by cause. Clin Med Res. 2011 Jun; 9(2):66-74.
32. Stata Corp. 2019. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC
33. UN Population https://www.un.org/en/sections/issues-depth/population/index.html accessed
April 1 2020
34. Chinazzi. M, Davis. JT, Ajelli. M, Gioannini. C, Litvinova. M, Merler. S, pastore. PY,
et.al.,The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19)
outbreak. Science. 2020 Mar 6
35. Wu.T, Leung. K, Leung.G.M, Now casting and forecasting the potential domestic and
international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modeling
study. Lancet 395, 689‚Äì697 (2020).
36. Du. Z, Wang.L, Cauchemez. S, Xu. X, Wang. X, Cowling. B.J, Meyers. L.A, Risk for
Transportation of 2019 Novel Coronavirus Disease from Wuhan to Other Cities in China.
Emerg Infect Dis. 2020 May 17;26(5).
37. Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S, Eggo RM et.al,
Early dynamics of transmission and control of COVID-19: a mathematical modelling study.
Lancet Infect Dis. 2020 Mar 11.
38. Gilbert.M, Pullano.G, Pinotti.F, Valdano. E, Poletto.C, Bo√´lle. P, D‚ÄôOrtenzio.E et.al.,
Preparedness and vulnerability of African countries against importations of COVID-19: a
modelling study Lancet 2020; 395: 871‚Äì77
39. Simiyu. S, Cairncross. S & Swilling. M. Understanding Living Conditions and Deprivation in
Informal Settlements of Kisumu, Kenya. Urban Forum 30, 223‚Äì241 (2019).
40. Wakhungu. J, Huhhins. C.D, Lumumba. J 2010 Approaches to informal urban settlements in
Africa: experiences from Kigali and Nairobi. Technical report. African Centre for Technology
Studies (ACTS)
41. G√ºneralp. B, Lwasa. S, Masundire. S, Parnell. S, and Seto. K.c Environmental Research
Letters, Volume 13, Number 1 Published 20 December 2017
42. AEO 2016 Africa Economic Outlook: Sustainable Cities and Structural Transformation
389 Report
43. Parpia. AS, Ndeffo-Mbah. ML, Wenzel. NS, Galvani. AP. Effects of Response to 2014‚Äì2015
Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerg
Infect Dis. 2016;22(3):433-441.
¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

16

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

44. O‚ÄôFallon. B, Barry. MA, Brodish. P, Hazerjian. J. Rapid Assessment of Ebola-Related
Implications for Reproductive, Maternal, Newborn and Child Health Service Delivery and
Utilization in Guinea. PLoS Curr. 2015 Aug 4;7.
45. Mullan. Z The Cost of Ebola Lancet Global Health. Editorial Volume 3, Issue 8. Aug 2015.
46. Elston. JW, Cartwright. C, Ndumbi. P, Wright. J. The health impact of the 2014‚Äì15 Ebola
outbreak. Public Health 2017; 143: 60‚Äì70.
47. Mekuria. LA, Rinke de Wit. TF, Spieker. N, Koech. R, Nyarango. R, et al., Analyzing data
from the digital healthcare exchange platform for surveillance of antibiotic prescriptions in
primary care in urban Kenya: A mixed-methods study. Plos one 14(11) 2019.
48. Guo. X, Chen. S, Zhang. X, Ju. X, Wang. X Exploring Patients' Intentions for Continuous
Usage of mHealth Services: Elaboration-Likelihood Perspective Study JMIR Mhealth Uhealth
2020;8(4):e17258
49. Lee. Jm, Newman. MW, Lee. Jm, Gebremariam. A, Choi. P, Lewis. D, Nordgren. W, Costik.
J, et.al., Real-World Use and Self-Reported Health Outcomes of a Patient-Designed Do-it
Yourself Mobile Technology System for Diabetes: Lessons for Mobile Health. Diabetes Technol
Ther. 2017 Apr;19(4):209-219.
50. Cahn. A, Akiroy. A, Raz. I Digital health technology and diabetes management. J
Diabetes. 2018 Jan;10(1) 10-17
51. Achoki T. Health Technology in Emerging Global Epidemics: An African Policy Perspective.
Georgetown Journal of International Affairs. Published 2016 July 22. Available at:
https://www.georgetownjournalofinternationalaffairs.org/online-edition/health-technologyin-emerging-global-epidemics-an-african-policy-perspective
52. GMSA report https://www.gsma.com/mobileeconomy/sub-saharan-africa/ accessed April 1
2020
53. Achoki. T, Hovels. A, Masiye. F, Lesego. A, Leufkens. H, Kinfu. Y. Technical and scale
efficiency in the delivery of child health services in Zambia: results from data envelopment
analysis. BMJ Open. 2017;7(1):e012321.
54. UNHCR Global trend https://www.unhcr.org/globaltrends2018/ accessed March 31
55. World Economic Forum https://www.weforum.org/agenda/2019/09/newly-released-datashow-refugee-numbers-at-record-levels/ accessed April 1 2020
56. OCHA Southern Africa Humanitarian Snapshot, accessed March 22 2020.
57. African Union, African Contiental Free Trade Agreement, https://au.int/en/cfta accessed
April 5 20202.

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

17

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

Appendix Figure A1: Observed and predicted COVID-19 cases, March 31, 2020

Appendix Table A1: Predication model performance from K-fold cross-validation test

Sub-sample number

Robustness
parameter

1

2

3

4

5

6

7

8

9

RMSE

1.476

1.457

1.483

1.449

1.483

1.484

1.485

1.487

1.485

MAE

1.114

1.141

1.128

1.137

1.159

1.139

1.146

1.134

1.143

Pseudo-R2

0.718

0.721

0.717

0.719

0.730

0.719

0.728

0.728

0.726

Note : RMSE, Root Mean Square Error; MAE, Mean Absolute Error.

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

18

medRxiv preprint doi: https://doi.org/10.1101/2020.04.09.20059154; this version posted April 28, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

MedRxiv: Africa and the COVID-19 pandemic

doi: https://doi.org/10.1101/2020.04.09.20059154

¬ß e-mail for corresponding author: yohannes.kinfu@canberra.edu.au

19

